Protecting Consumer Privacy in DTC Tissue Testing
The privatization of next-generation medical technologies, especially in regenerative and precision medicine, further muddies the data-protection waters.
merck
-
Read more: Protecting Consumer Privacy in DTC Tissue Testing -
Read more: Why We Should Care About the Move from Saliva to Living Cells in Precision Medicine Why We Should Care About the Move from Saliva to Living Cells in Precision Medicine
Could a corporate, direct-to-consumer cell-based testing service be the next 23andme? And what would that mean for patients?
-
Read more: Merck Price Negotiation Lawsuit May Face Same Obstacles as 340B Takings Claims Merck Price Negotiation Lawsuit May Face Same Obstacles as 340B Takings Claims
Past 340B litigation highlights that takings challenges to the Medicare price negotiation program face an uphill battle.
